Emmanuelle Charpentier: The Transformative Power of CRISPR-Cas9

The discovery that genome engineering could be accomplished by harnessing the bacterial CRISPR-Cas9 immune defense system is one of the most-important scientific breakthroughs of our time, as explained by 2018 Kavli Prize Laureate in Nanoscience, Dr. Emmanuelle Charpentier. Like a high-precision, programmable pair of molecular scissors, this incredible tool can be used to edit any genetic sequence—deleting, exchanging, and inserting. It has ushered in a new era in which genomic manipulation is no longer a bottleneck to discovery, transforming plant and animal biology, biotechnology, and human therapeutics. 


The Kavli Prize Carnegie lectures is Co-hosted by the Carnegie Institution for Science with The Kavli Foundation, the Royal Embassy of Norway, and the Norwegian Academy of Science and Letters. The Kavli Prize is a partnership between The Norwegian Academy of Science and Letters, The Kavli Foundation (United States), and The Norwegian Ministry of Education and Research.